Trade Balchem Corp - BCPC CFD

Balchem Company profile

About Balchem Corporation

Balchem Corporation is engaged in developing, manufacturing, distributing and marketing of specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. The Company operates through three business segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health (HNH) segment provides human grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications. HNH segment also serves the food and beverage industry for beverage, bakery, dairy, confectionary, and savory manufacturers. Its Animal Nutrition & Health (ANH) segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to basic choline chloride. The Specialty Products segment sells ethylene oxide as a sterilant gas primarily for use in the healthcare industry.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Balchem Corporation revenues increased 14% to $799M. Net income increased 14% to $96.1M. Revenues reflect Human nutrition & health segment increase of 11% to $442.7M, Animal Nutrition & Health segment increase of 18% to $226.8M, United States segment increase of 13% to $584.7M, Foreign Countries segment increase of 14% to $214.4M.

Equity composition

Common Stock $.0667 Par, 02/12, 60M auth., 29,210,260 issd., Insiders own 0.60%. PO: 12/69, 250K shs. @ $6 by A.J. Carno.12/90, 5-for-4 stock split. 12/91, 4-for-3 stock split.1/05, 6/98, 10/94, 01/06 & 01/07, 3-for-2 stock splits.12/06, Exchange changed from AMEX to NASDAQ. 01/10, 3-for-2 stock split.